Sign In
Buy MITO
$0.320
+0 (+0%)
At Close: Feb 14, 2023
Stealth BioTherapeutics (MITO) CEO Reenie McCarthy on Q3 2020 Results - Earnings Call Transcript
01:11pm, Saturday, 07'th Nov 2020
Stealth BioTherapeutics (MITO) CEO Reenie McCarthy on Q3 2020 Results - Earnings Call Transcript
Stealth BioTherapeutics Reports Third Quarter 2020 Financial Results And Recent Business Highlights
07:30am, Thursday, 05'th Nov 2020
BOSTON, Nov. 5, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies
Stealth BioTherapeutics Announces Development Financing To Advance Elamipretide Clinical Trials
05:00pm, Wednesday, 04'th Nov 2020
BOSTON, Nov. 4, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies
Stealth BioTherapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
04:30pm, Friday, 30'th Oct 2020
BOSTON, Oct. 30, 2020 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies
Stealth BioTherapeutics Corp (MITO) CEO Reenie McCarthy on Q2 2020 Earnings Call Transcript
07:52pm, Saturday, 08'th Aug 2020
Stealth BioTherapeutics Corp (NASDAQ:MITO) Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Ro
Stealth BioTherapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights
11:30am, Thursday, 06'th Aug 2020
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial
Stealth BioTherapeutics (NASDAQ:MITO) vs. Tetraphase Pharmaceuticals (NASDAQ:TTPH) Financial Review
02:24am, Wednesday, 05'th Aug 2020
Stealth BioTherapeutics (NASDAQ:MITO) and Tetraphase Pharmaceuticals (NASDAQ:TTPH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the s
Tetraphase Pharmaceuticals (NASDAQ:TTPH) & Stealth BioTherapeutics (NASDAQ:MITO) Financial Comparison
01:36am, Monday, 03'rd Aug 2020
Tetraphase Pharmaceuticals (NASDAQ:TTPH) and Stealth BioTherapeutics (NASDAQ:MITO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on
Stealth BioTherapeutics to Report Second Quarter 2020 Financial Results on Thursday, August 6, 2020
12:30pm, Thursday, 30'th Jul 2020
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial
Bolsonaro revives communications ministry in make-over - France 24
04:02pm, Saturday, 27'th Jun 2020
Bolsonaro revives communications ministry in make-over
Bolsonaro Revives Communications Ministry In Make-over
04:01pm, Saturday, 27'th Jun 2020
Bolsonaro revives communications ministry in make-over
HTG Molecular Diagnostics (HTGM) Gets a Buy Rating from H.C. Wainwright - Markets
10:18am, Friday, 19'th Jun 2020
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on HTG Molecular Diagnostics (HTGM –
Stealth BioTherapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
12:30pm, Wednesday, 17'th Jun 2020
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial
Doria announced partnership with China for anti-COVID-19 vaccine | Texto em inglês com áudio
04:13pm, Friday, 12'th Jun 2020
June 12th, 2020. Good evening. Yesterday, the governor of the Brazilian state of São Paulo, João Doria, announced that an experimental vaccine against COVID-19 produced by a Chinese laboratory w
